E. Livant

发表

Factors associated with bone mineral density in healthy African women

James Y. Dai, S. Greenspan, N. Mgodi, 2015, Archives of Osteoporosis.

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

B. Richardson, E. Livant, I. McGowan, 2011, AIDS.

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.

Ashley J. Mayo, J. Baeten, A. van der Straten, 2021, The lancet. HIV.

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.

A. van der Straten, D. Glidden, L. Benet, 2017, AIDS Research and Human Retroviruses.

Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015

F. Martinson, S. Riddler, E. Livant, 2016, HIV clinical trials.

Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

J. Baeten, A. van der Straten, F. Martinson, 2021, AIDS and Behavior.

Uptake and use of a vaginal ring containing dapivirine for HIV-1 prevention in African women: an open-label extension study

K. Bunge, E. Livant, K. Patterson, 2021 .

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.

Ashley J. Mayo, J. Baeten, A. van der Straten, 2016, The New England journal of medicine.

Ethnic variation in certain hematological and biochemical reference intervals in a south Indian healthy adult population.

E. Livant, N. Kumarasamy, S. Solomon, 2008, European journal of internal medicine.

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring.

Ashley J. Mayo, J. Baeten, J. Mellors, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

S. Riddler, E. Livant, G. Ramjee, 2017, PloS one.

Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial

J. Baeten, E. Livant, C. Hendrix, 2017, Journal of acquired immune deficiency syndromes.

Establishment of T-lymphocyte subset reference intervals in a healthy adult population in Chennai, India.

E. Livant, K. Mayer, S. Thyagarajan, 2009, The Indian journal of medical research.

The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.

J. Marrazzo, Z. Chirenje, C. Kelly, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Nutrient intakes of female adolescents from eight southern states.

M. Liebman, E. Livant, M. Korslund, 1984, Journal of the American Dietetic Association.

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.

A. van der Straten, D. Glidden, L. Benet, 2017 .

P587 Association between vaginal bacteria and HIV acquisition risk among african women participating in the VOICE study

S. Proll, J. Marrazzo, Z. Chirenje, 2019, Poster Presentations.